EndoQuest Robotics
EndoQuest Robotics is a Houston, Texas medical device company — founded in 2017 and operating as ColubrisMX until its June 2022 rebrand — developing what it calls the world's first flexible endoluminal robotic surgical system. Its Endoluminal Surgical (ELS) System pairs an ergonomic physician console (high-definition monitor, hand controllers, foot pedals) with a mobile patient cart and positioning arm, driving two 6mm flexible robotic instruments and a 3.7mm high-definition robotic camera through the EndoDrive, with up to seven degrees of freedom and additional channels for insufflation, suction, irrigation and third-party accessories. The design targets scar-free minimally invasive procedures inside the gastrointestinal tract — including appendectomy and cholecystectomy — performed through natural orifices or a single transumbilical incision. The company was accepted into the FDA's Safer Technologies Program in December 2023, received an investigational device exemption in December 2024, and began first colorectal cases in its PARADIGM pivotal multicenter study in May 2025. The system is not FDA-cleared and is not for commercial sale. EndoQuest sells surgical robotics hardware, not software: it publishes no API, developer portal, SDK, or machine-readable contract of any kind, and its nine-page marketing site carries no developer surface.
EndoQuest Robotics is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Surgical Robotics, Robotics, and Endoluminal Surgery.
EndoQuest Robotics’ developer surface includes engineering blog and 12 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 2
Properties that don't map to a standard resource type